Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions
Shyuan T. Ngo, Jia Mi, Robert D. Henderson, et al.
Degenerative Neurological and Neuromuscular Disease (2017) Vol. Volume 7, pp. 95-108
Open Access | Times Cited: 25

Showing 25 citing articles:

Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Timothy J. Tracey, Frederik J. Steyn, Ernst J. Wolvetang, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 330
Hypermetabolism in ALS is associated with greater functional decline and shorter survival
Frederik J. Steyn, Zara A. Ioannides, Ruben P.A. van Eijk, et al.
Journal of Neurology Neurosurgery & Psychiatry (2018) Vol. 89, Iss. 10, pp. 1016-1023
Open Access | Times Cited: 206
Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis
Shyuan T. Ngo, Ruben P.A. van Eijk, Veronique Chachay, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 20, Iss. 7-8, pp. 497-505
Open Access | Times Cited: 56
Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis
Frederik J. Steyn, Rui Li, Siobhan E. Kirk, et al.
Brain Communications (2020)
Open Access | Times Cited: 44
Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS
Aven Lee, Robert D. Henderson, James Aylward, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1871-1871
Open Access | Times Cited: 4
An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease
Jeryn Chang, Jinglei Lv, Christine C. Guo, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 31
Medical nutrition therapy in amyotrophic lateral sclerosis — Do we act or react? A case report and multidisciplinary review
Juan José López Gómez, Carmen Díaz Marín, Trinidad Castillo-García, et al.
Nutrición Hospitalaria (2024)
Open Access | Times Cited: 2
Blood–Brain Barrier Solute Carrier Transporters and Motor Neuron Disease
Sana Latif, Young‐Sook Kang
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 10
Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
Bożenna Kuraszkiewicz, Hanna Goszczyńska, T. Podsiadły-Marczykowska, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 15
Hypothalamus and weight loss in amyotrophic lateral sclerosis
Rebekah M. Ahmed, Frederik J. Steyn, Luc Dupuis
Handbook of clinical neurology (2021), pp. 327-338
Closed Access | Times Cited: 13
Associations of postprandial ghrelin, liver‐expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis
Stephanie L. Howe, Cory J. Holdom, Pamela McCombe, et al.
European Journal of Neurology (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 5
Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study
Omar Deeb, Maisa Nabulsi
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 26, pp. 2391-2403
Closed Access | Times Cited: 14
Ghrelin as a treatment for amyotrophic lateral sclerosis
Shyuan T. Ngo, Hao Wang, Robert D. Henderson, et al.
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 7
Closed Access | Times Cited: 10
The Alteration of L-Carnitine Transport and Pretreatment Effect under Glutamate Cytotoxicity on Motor Neuron-Like NSC-34 Lines
Asmita Gyawali, Seung Jae Hyeon, Hoon Ryu, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 551-551
Open Access | Times Cited: 8
Differences of Transport Activity of Arginine and Regulation on Neuronal Nitric Oxide Synthase and Oxidative Stress in Amyotrophic Lateral Sclerosis Model Cell Lines
Sana Latif, Young‐Sook Kang
Cells (2021) Vol. 10, Iss. 12, pp. 3554-3554
Open Access | Times Cited: 6
A Glutamate Scavenging Protocol Combined with Deanna Protocol in SOD1-G93A Mouse Model of ALS
Christopher Q. Rogers, Melissa Ramirez, Carol S. Landon, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1821-1821
Open Access | Times Cited: 2
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting?
Letizia Mazzini, Fabiola De Marchi, Elena Niccolai, et al.
Amyotrophic Lateral Sclerosis (2021), pp. 141-158
Open Access | Times Cited: 5
Weight gain-mediated recovery of metabolic and gut microbiome impairments in a TDP-43 mouse model of ALS
Laura Romero-Muñoz, Ana Belén Sanz-Martos, Marta Cabrera-Pinto, et al.
Research Square (Research Square) (2024)
Open Access
Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis (ALS)
Frederik J. Steyn, Siobhan E. Kirk, Tesfaye Wolde Tefera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 3
Diet, disease severity, and energy expenditure in amyotrophic lateral sclerosis (ALS)
Zoe Castles, Lauren E. Buckett, Leanne Jiang, et al.
Elsevier eBooks (2023), pp. 123-140
Closed Access | Times Cited: 1
Amyotrophic Lateral Sclerosis: From Mechanisms to Current, Emerging, and Alternative Therapeutics
Ivelina Kioutchoukova, Devon Foster, Rajvi Thakkar, et al.
Med Discoveries (2023) Vol. 2, Iss. 8
Closed Access | Times Cited: 1
The Small Molecule PPARγ Agonist GL516 Induces Feeding-Stimulatory Effects in Hypothalamus Cells Hypo-E22 and Isolated Hypothalami
Annalisa Chiavaroli, Viviana di Giacomo, Barbara De Filippis, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4882-4882
Open Access | Times Cited: 1
Motor Neuron Disease
Rahul Arora, Yusuf S. Khan
(2021)
Closed Access
MANEJO DIETÉTICO NA ESCLEROSE LATERAL AMIOTRÓFICA
Havena Mariana dos Santos Souza, Camila Melo de Araújo
(2021)
Open Access
Page 1

Scroll to top